Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
17.92
+3.61 (25.23%)
At close: Jan 9, 2026, 4:00 PM EST
19.66
+1.74 (9.71%)
After-hours: Jan 9, 2026, 7:59 PM EST
Intelligent Bio Solutions Market Cap
Intelligent Bio Solutions has a market cap or net worth of $21.79 million as of January 9, 2026. Its market cap has increased by 270.75% in one year.
Market Cap
21.79M
Enterprise Value
22.09M
1-Year Change
270.75%
Ranking
Category
Stock Price
$17.92
Market Cap Chart
Since December 23, 2020, Intelligent Bio Solutions's market cap has decreased from $108.04M to $21.79M, a decrease of -79.83%. That is a compound annual growth rate of -27.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 21.79M | 141.92% |
| Dec 31, 2025 | 9.01M | 46.68% |
| Dec 31, 2024 | 6.14M | 108.12% |
| Dec 29, 2023 | 2.95M | -19.57% |
| Dec 30, 2022 | 3.67M | -82.82% |
| Dec 31, 2021 | 21.36M | -74.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 968.61B |
| Johnson & Johnson | 494.36B |
| AbbVie | 392.34B |
| UnitedHealth Group | 311.69B |
| AstraZeneca | 295.31B |
| Merck & Co. | 276.45B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |